IP Library Patent Application 18812096
Patent Application
App. No. 18/812,096

CONTACT LENS TREATING SOLUTION

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
18/812,096
Abstract

A contact lens treating solution includes (a) about 0.005 to about 2 wt. %, based on the total weight of the contact lens treating solution, of hyaluronic acid or a salt thereof; (b) about 0.01 to about 1 wt. %, based on the total weight of the contact lens treating solution, of erythritol; (c) one or more nonionic surfactants; (d) sodium chloride, potassium chloride or any combination thereof; and (e) one or more buffers.

Claims (46)

1 . A method of cleaning and disinfecting a contact lens, comprising:

soaking the contact lens in a contact lens treating solution for at least about two hours, wherein the contact lens treating solution comprises:

(a) about 0.005 to about 2 wt. %, based on the total weight of the contact lens treating solution, of hyaluronic acid or a salt thereof;

(b) about 0.01 to about 1 wt. %, based on the total weight of the contact lens treating solution, of erythritol;

(c) one or more nonionic surfactants;

(d) one or more of sodium chloride and potassium chloride; and

(e) one or more buffers.

2 . The method of claim 1 , wherein the contact lens treating solution comprises:

(a) about 0.01 to about 0.2 wt. %, based on the total weight of the contact lens treating solution, of hyaluronic acid or a salt thereof; and

(b) about 0.05 to about 0.5 wt. %, based on the total weight of the contact lens treating solution, of erythritol.

3 . The method of claim 1 , wherein the one or more nonionic surfactants comprise one or more of a poloxamer and a poloxamine.

4 . The method of claim 1 , wherein the contact lens treating solution comprises:

(c) about 0.05 to about 5 wt. %, based on the total weight of the contact lens treating solution, of the one or more nonionic surfactants;

(d) about 0.01 to about 5 wt. %, based on the total weight of the contact lens treating solution, of the one or more of sodium chloride and potassium chloride; and

(e) about 0.1 to about 10% (w/w) of the one or more buffers.

5 . The method of claim 1 , wherein the contact lens treating solution further comprises one or more of one or more biguanide antimicrobial agents and one or more quaternary ammonium antimicrobial agents.

6 . The method of claim 5 , wherein the one or more biguanide antimicrobial agents comprise poly(hexamethylene biguanide) and alexidine, and the one or more quaternary ammonium antimicrobial agents comprise Polyquaternium-1.

7 . The method of claim 5 , wherein the contact lens treating solution comprises:

about 0.5 ppm to about 10 ppm, based on total weight of the contact lens treating solution, of the one or more biguanide antimicrobial agents; and

about 0.5 ppm to about 10 ppm, based on total weight of the contact lens treating solution, of the one or more quaternary ammonium antimicrobial agents.

8 . The method of claim 1 , wherein the contact lens treating solution satisfies the biocidal requirements of a Stand-Alone Procedure for Disinfecting Products.

9 . The method of claim 1 , wherein the contact lens treating solution is in the form of an eye care product or a contact lens care product selected from the group consisting of a contact lens preservative solution, a contact lens cleaning solution and a contact lens multi-purpose solution.

10 . The method of claim 1 , wherein soaking the contact lens in the contact lens treating solution comprises soaking the contact lens in the contact lens treating solution from about two hours to about twenty-four hours.

11 . A method of rewetting a contact lens, comprising:

administering a contact lens treating solution to a contact lens while worn on an eye, wherein the contact lens treating solution comprises:

(a) about 0.005 to about 2 wt. %, based on the total weight of the contact lens treating solution, of hyaluronic acid or a salt thereof;

(b) about 0.01 to about 1 wt. %, based on the total weight of the contact lens treating solution, of erythritol;

(c) one or more nonionic surfactants;

(d) one or more of sodium chloride and potassium chloride; and

(e) one or more buffers.

12 . The method of claim 11 , wherein the contact lens treating solution comprises:

(a) about 0.01 to about 0.2 wt. %, based on the total weight of the contact lens treating solution, of hyaluronic acid or a salt thereof; and

(b) about 0.05 to about 0.5 wt. %, based on the total weight of the contact lens treating solution, of erythritol.

13 . The method of claim 11 , wherein the one or more nonionic surfactants comprise one or more of a poloxamer and a poloxamine.

14 . The method of claim 11 , wherein the contact lens treating solution comprises:

(c) about 0.05 to about 5 wt. %, based on the total weight of the contact lens treating solution, of the one or more nonionic surfactants;

(d) about 0.01 to about 5 wt. %, based on the total weight of the contact lens treating solution, of the one or more of sodium chloride and potassium chloride; and

(e) about 0.1 to about 10% (w/w) of the one or more buffers.

15 . The method of claim 11 , wherein the contact lens treating solution further comprises one or more of one or more biguanide antimicrobial agents and one or more quaternary ammonium antimicrobial agents.

16 . The method of claim 15 , wherein the one or more biguanide antimicrobial agents comprise poly(hexamethylene biguanide) and alexidine, and the one or more quaternary ammonium antimicrobial agents comprise Polyquaternium-1.

17 . The method of claim 15 , wherein the contact lens treating solution comprises:

about 0.5 ppm to about 10 ppm, based on total weight of the contact lens treating solution, of the one or more biguanide antimicrobial agents; and

about 0.5 ppm to about 10 ppm, based on total weight of the contact lens treating solution, of the one or more quaternary ammonium antimicrobial agents.

18 . The method of claim 16 , wherein the contact lens treating solution further comprises ethylenediaminetetraacetic acid.

19 . The method of claim 11 , wherein the contact lens treating solution is in the form of an eye care product or a contact lens care product selected from the group consisting of a contact lens preservative solution and a contact lens rewetting solution.

20 . The method of claim 11 , wherein the contact lens treating solution is in the form of eye drops.

Assignments (6)
ASSIGNMENT OF SECURITY INTEREST IN PATENTS PREVIOUSLY RECORDED AT REEL/FRAME (069965/0938) Recorded Aug 14, 2025
From: CITIBANK, N.A., AS RESIGNING AGENT
To: JPMORGAN CHASE BANK, N.A., AS SUCCESSOR AGENT
Reel/Frame 072486/0720 →
PATENT SECURITY AGREEMENT Recorded Jul 1, 2025
From: BAUSCH & LOMB INCORPORATED; ALDEN OPTICAL LABORATORIES, INC.; BAUSCH + LOMB IRELAND LIMITED
To: CITIBANK, N.A., AS NOTES COLLATERAL AGENT
Reel/Frame 071773/0871 →
INTELLECTUAL PROPERTY SECURITY AGREEMENT Recorded Jan 22, 2025
From: BAUSCH + LOMB IRELAND LIMITED
To: CITIBANK, N.A., AS NOTES COLLATERAL AGENT
Reel/Frame 069989/0506 →
INTELLECTUAL PROPERTY SECURITY AGREEMENT Recorded Jan 21, 2025
From: BAUSCH + LOMB IRELAND LIMITED
To: CITIBANK, N.A., AS COLLATERAL AGENT
Reel/Frame 069965/0938 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 22, 2024
From: BARNIAK, VICKI; SCHEUER, CATHERINE; REINDEL, WILLIAM T.; DUEX, JOHN MICHAEL; GIALLOMBARDO, ANDREA E.
To: BAUSCH + LOMB IRELAND LIMITED
Reel/Frame 068368/0702 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 22, 2024
From: SUPERSAD, ELORA
To: BAUSCH + LOMB IRELAND LIMITED
Reel/Frame 068368/0845 →